Cargando…

Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions

Knowledge of the full target space of bioactive substances, approved and investigational drugs as well as chemical probes, provides important insights into therapeutic potential and possible adverse effects. The existing compound-target bioactivity data resources are often incomparable due to non-st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Jing, Tanoli, Zia-ur-Rehman, Ravikumar, Balaguru, Alam, Zaid, Rebane, Anni, Vähä-Koskela, Markus, Peddinti, Gopal, van Adrichem, Arjan J., Wakkinen, Janica, Jaiswal, Alok, Karjalainen, Ella, Gautam, Prson, He, Liye, Parri, Elina, Khan, Suleiman, Gupta, Abhishekh, Ali, Mehreen, Yetukuri, Laxman, Gustavsson, Anna-Lena, Seashore-Ludlow, Brinton, Hersey, Anne, Leach, Andrew R., Overington, John P., Repasky, Gretchen, Wennerberg, Krister, Aittokallio, Tero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814751/ https://www.ncbi.nlm.nih.gov/pubmed/29276046 http://dx.doi.org/10.1016/j.chembiol.2017.11.009

Ejemplares similares

A normalized drug response metric improves accuracy and consistency of anticancer drug sensitivity quantification in cell-based screening
por: Gupta, Abhishekh, et al.
Publicado: (2020)

Drug Target Commons 2.0: a community platform for systematic analysis of drug–target interaction profiles
por: Tanoli, ZiaurRehman, et al.
Publicado: (2018)

Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data
por: Potdar, Swapnil, et al.
Publicado: (2023)

Exploration of databases and methods supporting drug repurposing: a comprehensive survey
por: Tanoli, Ziaurrehman, et al.
Publicado: (2020)

Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors
por: Cichonska, Anna, et al.
Publicado: (2017)

TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples
por: He, Liye, et al.
Publicado: (2015)

Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells
por: Gautam, Prson, et al.
Publicado: (2016)

Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach
por: Ali, Mehreen, et al.
Publicado: (2018)

C-SPADE: a web-tool for interactive analysis and visualization of drug screening experiments through compound-specific bioactivity dendrograms
por: Ravikumar, Balaguru, et al.
Publicado: (2017)

From drug response profiling to target addiction scoring in cancer cell models
por: Yadav, Bhagwan, et al.
Publicado: (2015)

Using BERT to identify drug-target interactions from whole PubMed
por: Aldahdooh, Jehad, et al.
Publicado: (2022)

Multi‐modal meta‐analysis of cancer cell line omics profiles identifies ECHDC1 as a novel breast tumor suppressor
por: Jaiswal, Alok, et al.
Publicado: (2021)

DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features
por: Wang, Yinyin, et al.
Publicado: (2022)

Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer
por: Tang, Jing, et al.
Publicado: (2019)

Identification of novel regulators of STAT3 activity
por: Parri, Elina, et al.
Publicado: (2020)

Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency Model
por: Yadav, Bhagwan, et al.
Publicado: (2015)

Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring
por: Mäkinen, Lotta, et al.
Publicado: (2022)

Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells
por: Jaiswal, Alok, et al.
Publicado: (2017)

Corrigendum to “Searching for drug synergy in complex dose–response landscapes using an interaction potency model” [Comput. Struct. Biotechnol. J. 13 (2015) 504–513]
por: Yadav, Bhagwan, et al.
Publicado: (2017)

Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression
por: Ammad-ud-din, Muhammad, et al.
Publicado: (2017)

Minimal information for Chemosensitivity assays (MICHA): A next-generation pipeline to enable the FAIRification of drug screening experiments
por: Tanoli, Ziaurrehman, et al.
Publicado: (2021)

Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments
por: Tanoli, Ziaurrehman, et al.
Publicado: (2021)

Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
por: Ianevski, Aleksandr, et al.
Publicado: (2021)

Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling
por: Kuusanmäki, Heikki, et al.
Publicado: (2017)

Systematic mapping of cancer cell target dependencies using high-throughput drug screening in triple-negative breast cancer
por: Wang, Tianduanyi, et al.
Publicado: (2020)

Discovery of MINC1, a GTPase-Activating Protein Small Molecule Inhibitor, Targeting MgcRacGAP
por: van Adrichem, Arjan J., et al.
Publicado: (2015)

What is synergy? The Saariselkä agreement revisited
por: Tang, Jing, et al.
Publicado: (2015)

Machine learning and feature selection for drug response prediction in precision oncology applications
por: Ali, Mehreen, et al.
Publicado: (2018)

Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells
por: Denisova, Oxana V., et al.
Publicado: (2022)

Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose–response data
por: Mpindi, John-Patrick, et al.
Publicado: (2015)

Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects
por: Julkunen, Heli, et al.
Publicado: (2020)

MediSyn: uncertainty-aware visualization of multiple biomedical datasets to support drug treatment selection
por: He, Chen, et al.
Publicado: (2017)

Improved detection of differentially represented DNA barcodes for high‐throughput clonal phenomics
por: Akimov, Yevhen, et al.
Publicado: (2020)

The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients
por: Åkerlund, Emma, et al.
Publicado: (2023)

Breeze: an integrated quality control and data analysis application for high-throughput drug screening
por: Potdar, Swapnil, et al.
Publicado: (2020)

SynergyFinder: a web application for analyzing drug combination dose–response matrix data
por: Ianevski, Aleksandr, et al.
Publicado: (2017)

SynergyFinder: a web application for analyzing drug combination dose–response matrix data
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

A Portable, Negative-Pressure Actuated, Dynamically Tunable Microfluidic Droplet Generator
por: Trossbach, Martin, et al.
Publicado: (2022)

Bioluminescent, Nonlytic, Real-Time Cell Viability Assay and Use in Inhibitor Screening
por: Duellman, Sarah J., et al.
Publicado: (2015)

Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies
por: Yadav, Bhagwan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t7c0g4tq4h44888ql6fvm0111e